Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population.
Hlavacek P, Guo JD, Rosenblatt L, Keshishian A, Russ C, Mardekian J, Ferri M, Poretta T, Yuce H, McBane R. Hlavacek P, et al. Among authors: rosenblatt l. Curr Med Res Opin. 2019 Dec;35(12):2043-2051. doi: 10.1080/03007995.2019.1653067. Epub 2019 Sep 3. Curr Med Res Opin. 2019. PMID: 31387467
Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database.
Guo JD, Rajpura J, Hlavacek P, Keshishian A, Sah J, Delinger R, Mu Q, Mardekian J, Russ C, Okano GJ, Rosenblatt L. Guo JD, et al. Among authors: rosenblatt l. J Manag Care Spec Pharm. 2020 Aug;26(8):1017-1026. doi: 10.18553/jmcp.2020.19311. Epub 2020 May 26. J Manag Care Spec Pharm. 2020. PMID: 32452277 Free PMC article.
Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis.
Cohen A, Keshishian A, Lee T, Wygant G, Rosenblatt L, Hlavacek P, Mardekian J, Wiederkehr D, Sah J, Luo X. Cohen A, et al. Among authors: rosenblatt l. Thromb Haemost. 2021 Mar;121(3):383-395. doi: 10.1055/s-0040-1718728. Epub 2020 Nov 10. Thromb Haemost. 2021. PMID: 33171521 Free PMC article.
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
Guo JD, Hlavacek P, Rosenblatt L, Keshishian A, Russ C, Mardekian J, Ferri M, Poretta T, Yuce H, McBane R. Guo JD, et al. Among authors: rosenblatt l. Thromb Res. 2021 Feb;198:163-170. doi: 10.1016/j.thromres.2020.11.039. Epub 2020 Dec 8. Thromb Res. 2021. PMID: 33348190 Free article.
170 results